Join
Live feed
·
PRReleasevia Quantisnow
PHAXIAM Therapeutics S.A.. logo

PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHXM (PHAXIAM Therapeutics S.A..) and more on Quantisnow.